Copyright
©The Author(s) 2024.
World J Exp Med. Sep 20, 2024; 14(3): 96042
Published online Sep 20, 2024. doi: 10.5493/wjem.v14.i3.96042
Published online Sep 20, 2024. doi: 10.5493/wjem.v14.i3.96042
Application area | AI techniques used | Key benefits | Challenges |
Target identification | Machine learning, deep learning | Identifying novel drug targets, high accuracy | Data quality, complexity of biological systems |
Drug screening | Virtual screening, predictive models | Faster screening of compounds, cost-effective | False positives/negatives, model validation |
Lead optimization | QSAR models, reinforcement learning | Improved candidate selection, reduced development time | Integration with traditional methods, data scarcity |
Preclinical development | Image analysis, natural language processing | Enhanced understanding of drug toxicity and efficacy | Interpretation of complex data, standardization |
Clinical trials | Predictive analytics, patient recruitment algorithms | Optimized trial design, better patient stratification | Ethical concerns, data privacy |
Personalized medicine | Genomic data analysis, personalized algorithms | Tailored treatments, improved patient outcomes | Data integration, regulatory issues |
- Citation: Kokudeva M, Vichev M, Naseva E, Miteva DG, Velikova T. Artificial intelligence as a tool in drug discovery and development. World J Exp Med 2024; 14(3): 96042
- URL: https://www.wjgnet.com/2220-315x/full/v14/i3/96042.htm
- DOI: https://dx.doi.org/10.5493/wjem.v14.i3.96042